Skip to main content
Clinical Trials/CTRI/2023/04/051304
CTRI/2023/04/051304
Recruiting
未知

Single-arm clinical study to evaluate the analgesic effect of Trailokya Vijaya Vati Plus (Formulation femme) in Primary Dysmenorrhea.

Amrita School of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N944- Primary dysmenorrhea
Sponsor
Amrita School of Ayurveda
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amrita School of Ayurveda

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects with regular menstrual periods lasting
  • 21 to 35 days and menstruation lasting for 3 to
  • 2\. Subjects who give consent for the study.
  • 3\. Other causes of pain excluded using USG.
  • 4\. Screened Subjects will be assessed by:Clinical
  • history and physical examination,
  • Haematological: Hb,ESR, CBC, Serum SGOT, SGPT \&
  • Serum BUN and Creatinine within 1\.5 times the
  • upper limit of normal range detected at
  • screening, Urine analysis and USG.

Exclusion Criteria

  • 1\. Subjects having Dysmenorrhea secondary to
  • organic pathologies
  • 2\. Subjects with irregular menstrual bleeding
  • 3\. Subjects having a severe gynaecological illness
  • like uterine pathology fibroid adenomyosis
  • endometriosis etc
  • 4\. Subjects with autoimmune diseases gynaecological Surgeries and genitourinary infections
  • 5\. Subjects under hormonal therapy
  • 6\. History or documentation of chronic illnesses
  • eg Diabetes hypertension Hypothyroidism bronchial asthma Gastroesophageal Reflux

Outcomes

Primary Outcomes

Not specified

Similar Trials